EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Strategies for Synthesizing and Enhancing the Immune Response of Cancer Vaccines Based on MUC1 Glycopeptide Antigens

Lixin Yin, Yang Zhou, Sheng Hong, Feiqing Ding, Hui Cai iD

ChemBioChem · 2023

DOI: 10.1002/cbic.202200805 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift ChemBioChem, 2023. Verfasst von Lixin Yin und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences (Shenzhen), Shenzhen Campus of Sun Yat-sen University, 66 Gongchang Lu, Guangming District, Shenzhen, 518107, China. Hauptthemen laut MEDLINE: Cancer Vaccines, Neoplasms. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 139 Literaturangaben. Gefördert von: Sun Yat-sen University, Basic and Applied Basic Research Foundation of Guangdong Province, Fundamental Research Funds for the Central Universities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer vaccines are based on a vaccinology strategy whereby the patient's immune system is harnessed to induce a specific immune response to kill cancer cells and comprises two categories: prophylactic and therapeutic. Glycoprotein mucin 1 (MUC1), which is overexpressed and poorly glycosylated on cancer cells, is one of the most promising candidates for the development of new cancer vaccines. However, it should be noted that mucin‐like glycopeptides are poorly immunogenic and unable to elicit effective and long‐lasting immune responses. Therefore, MUC1‐derived tumor antigens need to be conjugated with immune activators. This review focuses on the synthesis of MUC1 glycopeptides, provides an overview of recently advanced designs of vaccines based on MUC1, and compares the advantages and disadvantages of the various strategies devised to date.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cancer VaccinesNeoplasmsHumansMucin-1GlycopeptidesImmunity

Stichwörter der Autor:innen

Glycopeptide synthesisMUC1cancer vaccinemulticomponentmultivalent

Substanzen

Mucin-1Cancer VaccinesGlycopeptidesMUC1 protein, human

Autor:innen und Institutionen

  • School of Pharmaceutical Sciences (Shenzhen), Shenzhen Campus of Sun Yat-sen University, 66 Gongchang Lu, Guangming District, Shenzhen, 518107, China.

ORCID-Profile: Hui Cai

Förderung

  • Sun Yat-sen University
  • Basic and Applied Basic Research Foundation of Guangdong Province
  • Fundamental Research Funds for the Central Universities
  • National Natural Science Foundation of China

Zitieren

APA

Yin, L., Zhou, Y., Hong, S., Ding, F., & Cai, H. (2023). Strategies for Synthesizing and Enhancing the Immune Response of Cancer Vaccines Based on MUC1 Glycopeptide Antigens. ChemBioChem. https://doi.org/10.1002/cbic.202200805

Vancouver

Yin L, Zhou Y, Hong S, Ding F, Cai H. Strategies for Synthesizing and Enhancing the Immune Response of Cancer Vaccines Based on MUC1 Glycopeptide Antigens. ChemBioChem. 2023. doi:10.1002/cbic.202200805

BibTeX
@article{Yin2023,
  author = {Yin, Lixin and Zhou, Yang and Hong, Sheng and Ding, Feiqing and Cai, Hui},
  title = {Strategies for Synthesizing and Enhancing the Immune Response of Cancer Vaccines Based on MUC1 Glycopeptide Antigens},
  journal = {ChemBioChem},
  year = {2023},
  doi = {10.1002/cbic.202200805}
}
Kostenlos starten →